Target Price | HK$11.42 |
Price | HK$9.40 |
Potential |
21.53%
register free of charge
|
Number of Estimates | 26 |
26 Analysts have issued a price target CSPC Pharmaceutical Group Limited 2026 .
The average CSPC Pharmaceutical Group Limited target price is HK$11.42.
This is
21.53%
register free of charge
HK$18.27
94.36%
register free of charge
HK$5.05
46.28%
register free of charge
|
|
A rating was issued by 32 analysts: 22 Analysts recommend CSPC Pharmaceutical Group Limited to buy, 8 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CSPC Pharmaceutical Group Limited stock has an average upside potential 2026 of
21.53%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HK$ | 31.67 | 32.67 |
7.76% | 3.15% | |
EBITDA Margin | 24.03% | 28.25% |
10.70% | 17.56% | |
Net Margin | 14.92% | 18.09% |
20.11% | 21.25% |
29 Analysts have issued a sales forecast CSPC Pharmaceutical Group Limited 2025 . The average CSPC Pharmaceutical Group Limited sales estimate is
This results in the following potential growth metrics:
29 CSPC Pharmaceutical Group Limited Analysts have issued a net profit forecast 2025. The average CSPC Pharmaceutical Group Limited net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HK$ | 0.40 | 0.51 |
25.93% | 27.50% | |
P/E | 18.32 | |
EV/Sales | 3.15 |
29 Analysts have issued a CSPC Pharmaceutical Group Limited forecast for earnings per share. The average CSPC Pharmaceutical Group Limited EPS is
This results in the following potential growth metrics and future valuations:
CSPC Pharmaceutical Group Limited...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.